CTRI/2026/02/104478尚未招募2/3 期
Randomized Open Labelled Controlled Clinical Study to Evaluate The Efficacy Of Pippalyadi Churna With Ghrita In Oligomenorrhoea.
Manjusha Rupchand Meshram1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年3月3日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Efficacy of Pippalyadi churna evaluated by interval between two menstrual cycle and amount of menstrual bleeding increases for 3 consecutive menstrual cycle
研究概览
简要总结
This study is Randomized Open labelled Controlled Clinical study of efficacy of Pippalyadi Churna 5 gm with Ghrita 10 ml from 2 nd day of menstruation for 10 days in Oligomenorrhea for 3 menstrual cycle. This study will be carried out in 2 years of PG course.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients having primary or secondary Amenorrhea.
- •Pregnant women, Lactating mothers, perimenopausal and menopausal women.
- •Patients having PCOS with heavy menstrual bleeding and Hypogonadotropic, Hypogonadism, premature ovarian failure, and other pituitary ovarian syndrome.
- •Patients take Oral Contraceptive Pills within 3 months, Hormonal therapy used for obesity and diabetes etc, taking radiation therapy within 3 years.
- •Patients suffering from Endocrine disorders, Diabetic Mellitus, Thyroid dysfunction, Hyperprolactinemia, Cushing syndrome, Cardiovascular disorders Psychological, Epileptic disorders etc.
- •Patients having Excessive menstrual bleeding disorders, systemic diseases like Tuberculosis, Anorectal bleeding, GIT tract Ulcers, STD Infections.
- •Patients with any congenital anomalies, malignantlesions, obstructed and pelvic pathology in the reproductive system.
排除标准
- •Patients having primary or secondary Amenorrhea.
- •Pregnant women, Lactating mothers, perimenopausal and menopausal women.
- •Patients having PCOS with heavy menstrual bleeding and Hypogonadotropic, Hypogonadism, premature ovarian failure, and other pituitary ovarian syndrome.
- •Patients take Oral Contraceptive Pills within 3 months, Hormonal therapy used for obesity and diabetes etc, taking radiation therapy within 3 years.
- •Patients suffering from Endocrine disorders, Diabetic Mellitus, Thyroid dysfunction, Hyperprolactinemia, Cushing syndrome, Cardiovascular disorders Psychological, Epileptic disorders etc.
- •Patients having Excessive menstrual bleeding disorders, systemic diseases like Tuberculosis, Anorectal bleeding, GIT tract Ulcers, STD Infections.
- •Patients with any congenital anomalies, malignantlesions, obstructed and pelvic pathology in the reproductive system.
结局指标
主要结局
Efficacy of Pippalyadi churna evaluated by interval between two menstrual cycle and amount of menstrual bleeding increases for 3 consecutive menstrual cycle
时间窗: 10 days
次要结局
未报告次要终点
研究者
Manjusha Rupchand Meshram
Government Ayurved College Nanded
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
Compare two interventional group to study the efficacy of Pippali churna and Vidarikand Churna in the management of stanyakshayCTRI/2025/04/085341Dr Sheela Natharo Bhalerao80
尚未招募
不适用
Role of Nidrakar Churna and Shiropichu with Ksheerbala Taila in improving sleep among patients with InsomniaCTRI/2025/09/095493Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan60
尚未招募
2 期
A Study to see the Effect of Pathadi Churna and Mridvikadi Churna in Treatment Tonsillitis (Tundikeri) in ChildrenCTRI/2025/09/095431Institute for Ayurved Studies and Research66
尚未招募
2 期
A Clinical Study to assess the effect of Rajanyadi Churna in the management of Iron Deficiency Anemia (Pandu Rago) in Children.CTRI/2025/10/096288Gunjal Priya30
尚未招募
2 期
A clinical study to evaluate the effectiveness of an Ayurvedic formulation in women with ovulation-related menstrual problems.CTRI/2026/02/103113YMT Ayurvedic Medical College and Hospital92